Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.0059 | 1 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |